| Benign | Malignant |
---|---|---|
Number | 186 | 273 |
Age, mean (range) (year) | 65.23 (30–89) | 70.21 (49–87) |
tPSA (ng/ml), mean (range) | 13.62 (1.64-136.45) | 28.95 (2.85-211.87) |
f/tPSA, mean (range) | 0.16 (0.03–0.40) | 0.13 (0.02–0.43) |
PI-RADS v2, median (range) | 3 (2–5) | 4 (3–5) |
Positive core percentage, mean (range) | - | 0.41 (0.08-1) |
BiopsyGS, median (range) | - | 7 (6–10) |
ECE reported by MRI | - | 25 |
ECE on postoperative pathology, n | - | 113 |
   reported by MRI, n (%) | - | 23 (20.4) |
   not reported by MRI, n (%) | - | 90 (79.6) |
PSM on postoperative pathology, n | - | 101 |
   PSM with ECE, n (%) | - | 68 (67.3) |
   PSM without ECE, n (%) | - | 33 (32.7) |
Pathologic stage | - | Â |
   pT2, n (%) | - | 160 (58.6) |
   pT3, n (%) | - | 113 (41.4) |